Dow Up 0.51% Nasdaq Up 0.24%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
4.20 Down 0.15(3.45%) Nov 21, 4:00PM EST
Prev Close:4.35
Open:4.43
Bid:4.19 x 2700
Ask:4.20 x 3200
1y Target Est:24.00
Beta:1.47
Next Earnings Date:N/A
Day's Range:4.18 - 4.47
52wk Range:4.01 - 19.11
Volume:122,986
Avg Vol (3m):265,409
Market Cap:92.92M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTDown 3.45%92.92M
MNTAUp 1.68%593.80M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.90
Quarterly EPS Est (Dec-14) :-0.22
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback